Please assess the completion status of the following clinical trial:

Trial Title: Randomized-controlled Trial of a Combined vs. Conventional Percutaneous Intervention for Near-Infrared Spectroscopy Defined High-Risk Native Coronary Artery Lesions

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age ≥18 years.~2. Willing and able to provide informed consent and able to comply with study procedures and follow-up.~3. Undergoing a clinically indicated left heart coronary catheterization~4. Need PCI of a high-risk native coronary artery lesion. High-risk lesions will be defined as lesions with ≥2 contiguous yellow blocks on block chemogram.~Exclusion Criteria:~1. Coexisting conditions that limit life expectancy to less than 30-days or that could affect the patient's compliance with the protocol.~2. Positive pregnancy test or breast-feeding.~3. High risk for bleeding.~4. Subject is currently, or within the 30 preceding days, participating in a device or pharmaceutical treatment protocol.~5. Clinical presentation with ST-segment elevation MI.~6. Persistent (\>10 minutes) hypotension (systolic blood pressure \<90 mmHg)~7. Need for revascularization of multiple lesions during the index PCI.~8. Unprotected left main (\>50%) or equivalent left main disease.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Combined Intervention (Type: ACTIVE_COMPARATOR): Combined intervention: pre-PCI intracoronary vasodilator and glycoprotein IIb/IIIa inhibitor administration, use of an EPD if technically feasible, and complete coverage of the lipid core plaque, if technically feasible
- Conventional PCI (Type: ACTIVE_COMPARATOR): Conventional PCI

Based on this trial design, predict the completion outcome and termination type (if applicable).